Chemical Compound

4H-Bis[1,3]benzodioxolo[5,6-a:4',5'-g]quinolizine, 6,7,12b,13-tetrahydro-; Berbine, 2,3:9,10-bis(methylenedioxy)-, (+/-)- (8CI); 6,7,12b,13-Tetrahydro-4H-bis[1,3]benzodioxolo[5,6-a:4',5'-g]quinolizine; (RS)-Stylopine; (+/-)-Stylopine; (+/-)-Tetrahydrocoptisine; 2,3:9,10-Bis(methylenedioxy)berbine; Chelidamine; NSC 110382; NSC 404529; Tetrahydrocoptisine; dl-Stylopine; dl-Tetrahydrocoptisine

CAS Registry Number 4312-32-7
4H-Bis[1,3]benzodioxolo[5,6-a:4',5'-g]quinolizine, 6,7,12b,13-tetrahydro-; Berbine, 2,3:9,10-bis(methylenedioxy)-, (+/-)- (8CI); 6,7,12b,13-Tetrahydro-4H-bis[1,3]benzodioxolo[5,6-a:4',5'-g]quinolizine; (RS)-Stylopine; (+/-)-Stylopine; (+/-)-Tetrahydrocoptisine; 2,3:9,10-Bis(methylenedioxy)berbine; Chelidamine; NSC 110382; NSC 404529; Tetrahydrocoptisine; dl-Stylopine; dl-Tetrahydrocoptisine 结构式
Primary record

4H-Bis[1,3]benzodioxolo[5,6-a:4',5'-g]quinolizine, 6,7,12b,13-tetrahydro-; Berbine, 2,3:9,10-bis(methylenedioxy)-, (+/-)- (8CI); 6,7,12b,13-Tetrahydro-4H-bis[1,3]benzodioxolo[5,6-a:4',5'-g]quinolizine; (RS)-Stylopine; (+/-)-Stylopine; (+/-)-Tetrahydrocoptisine; 2,3:9,10-Bis(methylenedioxy)berbine; Chelidamine; NSC 110382; NSC 404529; Tetrahydrocoptisine; dl-Stylopine; dl-Tetrahydrocoptisine

库存
8,320 克
纯度
98.4 %
CAS
4312-32-7

化合物标识与属性

CAS
4312-32-7
PubChem CID
6770
SMILES
C1CN2CC3=C(CC2C4=CC5=C(C=C41)OCO5)C=CC6=C3OCO6
Canonical SMILES
c1cc2c(c3c1CC1c4cc5c(cc4CCN1C3)OCO5)OCO2

名称与同义词

  • Tetrahydrocoptisine
  • Stylopine
  • dl-Stylopine
  • Stylopin
  • Chelidamine
  • (-)-STYLOPINE
  • (R,S)-Stylopine
  • l-Stylopine
  • (RS)-Stylopine
  • 4312-32-7
  • (S)-Stylopine
  • tetrahyrocoptisine
  • tetrahyrocoptision
  • l-Tetrahydrocoptisine
  • (+-)-Stylopine
  • (S)-Stylopin
  • dl-Tetrahydrocoptisine
  • (-)-Tetrahydrocoptisine
  • Coptisine, tetrahydro-
  • D,L-tetrahydrocoptisine
  • (.+-.)-Stylopine
  • (.+/-.)-Stylopine
  • ( )-Tetrahydrocoptisine
  • (+-)-Tetrahydrocoptisine
  • (.+-.)-Tetrahydrocoptisine
  • RefChem:1049045
  • C19H17NO4
  • Stylopine, (.+-.)-
  • AC1L1N9M
  • AC1Q6ZR8
  • ARSENAZOITRISODIUMSALT
  • Stylopine (Trahydocoptisine)
  • UNII-J0JS75Q12Z
  • ( inverted exclamation markA)-Stylopine
  • 7461-02-1 (racemic)
  • Oprea1_614048
  • Stylopine, (.+/-.)-
  • orb105523
  • SCHEMBL433598
  • DTXSID50904180
  • (.+/-.)-Tetrahydrocoptisine
  • Stylopine (Tetrahydrocoptisine)
  • orb1302288
  • STYLOPINE, (-)-(RG)(CALL)
  • CHEMBL3343660
  • NSC 110382
  • SCHEMBL29706696
  • CID6770
  • UXYJCYXWJGAKQY-UHFFFAOYSA-N
  • DTXCID401332424
  • GLXC-05669
  • STYLOPINE (REFERENCE GRADE)
  • HAA46102
  • HY-N0924
  • STYLOPINE, (+/-)-(P)
  • 5963AB
  • AR-1L5695
  • C19-H17-N-O4
  • MFCD00075989
  • MFCD00266447
  • NSC110382
  • NSC404529
  • s3304
  • 7461-02-1
  • AKOS000277992
  • AKOS016843796
  • 2,3:9,10-Bis(methylenedioxy)berbine
  • ACN-057032
  • CS-4250
  • EBC-462090
  • FT73995
  • NSC 404529
  • NSC-110382
  • NSC-404529
  • 6,7,12b,13-Tetrahydro-4H-[1,3]dioxolo[4',5':7,8]isoquinolino[3,2-a][1,3]dioxolo[4,5-g]isoquinoline
  • TETRAHYDROCOPTISINE;(-)-STYLOPINE
  • AS-77471
  • LS-43447
  • ST023430
  • DB-050264
  • J263.139C
  • ( )-2,3:9,10-Bis(methylenedioxy)berbine
  • 2,3:9,10-Bis(methylenedioxy)-13a-alpha-berbine
  • 84-39-9
  • F17720
  • ( inverted exclamation markA)-Tetrahydrocoptisine
  • 5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.02,10.04,8.015,23.016,20]tetracosa-2,4(8),9,15(23),16(20),21-hexaene
  • A872754
  • AC-542/20643024
  • 13a-alpha-BERBINE, 2,3:9,10-BIS(METHYLENEDIOXY)-
  • Berbine,3:9,10-bis(methylenedioxy)-, (.+-.)-
  • Berbine, 2,3:9,10-bis(methylenedioxy)-, (.+.)-
  • Q28603617
  • Berbine, 2,3:9,10-bis(methylenedioxy)-, (.+/-.)-
  • Berbine, 2,3:9,10-bis(methylenedioxy)-, (+-)- (8CI)
  • ( inverted exclamation markA)- 2,3:9,10-Bis(methylenedioxy)berbine
  • 4H-Bis[1,6-a:4',5'-g]quinolizine, 6,7,12b,13-tetrahydro-
  • 4H-Bis[1,6-a:4',5'-g]quinolizine, 6,7,12b,13-tetrahydro-, (.+-.)-
  • 4H-Bis(1,3)benzodioxolo(5,6-a:4',5'-g)quinolizine, 6,7,12b,13-tetrahydro-, (S)-
  • 4H-Bis[1,3]benzodioxolo[5,6-a:4',5'-g]quinolizine, 6,7,12b,13-tetrahydro-
  • 4H-Bis[1,3]benzodioxolo[5,6-a:4',5'-g]quinolizine, 6,7,12b,13-tetrahydro-, (.+.)-
  • 4H-Bis[1,3]benzodioxolo[5,6-a:4',5'-g]quinolizine, 6,7,12b,13-tetrahydro-, (.+/-.)-
  • 6,7,12b,13-Tetrahydro-4H-bis[1,3]benzodioxolo[5,6-a:4 ,5 -g]quinolizine
  • 6,7,12b,13-Tetrahydro-4H-bis[1,3]benzodioxolo[5,6-a:4',5'-g]quinolizine
  • (1S)-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.02,10.04,8.015,23.016,20]tetracosa-2,4(8),9,15(23),16(20),21-hexaene
  • 4H-Bis[1,3]benzodioxolo[5,6-a:4',5'-g]quinolizine, 6,7,12b,13-tetrahydro-; Berbine, 2,3:9,10-bis(methylenedioxy)-, (+/-)- (8CI); 6,7,12b,13-Tetrahydro-4H-bis[1,3]benzodioxolo[5,6-a:4',5'-g]quinolizine; (RS)-Stylopine; (+/-)-Stylopine; (+/-)-Tetrahydrocoptisine; 2,3:9,10-Bis(methylenedioxy)berbine; Chelidamine; NSC 110382; NSC 404529; Tetrahydrocoptisine; dl-Stylopine; dl-Tetrahydrocoptisine
  • 5,6,7,8,14,14a-hexahydro-2H,10H-1,3-dioxolano[4',5'-6,7]isoquinolino[2,1-b]1,3 -dioxoleno[4,5-h]isoquinoline
  • 5,7,17,19-tetraoxa-13-azahexacyclo(11.11.0.02,10.04,8.015,23.016,20)tetracosa-2,4(8),9,15(23),16(20),21-hexaene
  • 5,7,17,19-TETRAOXA-13-AZAHEXACYCLO[11.11.0.0(2),(1)?.0?,?.0(1)?,(2)(3).0(1)?,(2)?]TETRACOSA-2,4(8),9,15(23),16(20),21-HEXAENE
  • 5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0^{2,10}.0^{4,8}.0^{15,23}.0^{16,20}]tetracosa-2(10),3,8,15,20,22-hexaene
  • 5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.02,10.04,8.015,23.016,20]tetracosa-2(10),3,8,15,20,22-hexaene
  • 6,7,12b,13-Tetrahydro-2H,4H,10H-[1,3]dioxolo[4,5-g][1,3]dioxolo[7,8]isoquinolino[3,2-a]isoquinoline
  • 6,7,12b,13-Tetrahydro-4H-[1,3]dioxolo[4,5-g][1,3]dioxolo[4',5':7,8]isoquino[3,2-a]isoquinoline #
  • 90153-59-6